Advertisement

Pharmaceutical Research

, Volume 31, Issue 8, pp 1989–1999 | Cite as

Hydrogel-Forming Microneedle Arrays Can Be Effectively Inserted in Skin by Self-Application: A Pilot Study Centred on Pharmacist Intervention and a Patient Information Leaflet

  • Ryan F. DonnellyEmail author
  • Kurtis Moffatt
  • Ahlam Zaid Alkilani
  • Eva M. Vicente-Pérez
  • Johanne Barry
  • Maelíosa T. C. McCrudden
  • A. David Woolfson
Research Paper

Abstract

Purpose

To investigate, for the first time, the influence of pharmacist intervention and the use of a patient information leaflet on self-application of hydrogel-forming microneedle arrays by human volunteers without the aid of an applicator device.

Methods

A patient information leaflet was drafted and pharmacist counselling strategy devised. Twenty human volunteers applied 11 × 11 arrays of 400 μm hydrogel-forming microneedle arrays to their own skin following the instructions provided. Skin barrier function disruption was assessed using transepidermal water loss measurements and optical coherence tomography and results compared to those obtained when more experienced researchers applied the microneedles to the volunteers or themselves.

Results

Volunteer self-application of the 400 μm microneedle design resulted in an approximately 30% increase in skin transepidermal water loss, which was not significantly different from that seen with self-application by the more experienced researchers or application to the volunteers. Use of optical coherence tomography showed that self-application of microneedles of the same density (400 μm, 600 μm and 900 μm) led to percentage penetration depths of approximately 75%, 70% and 60%, respectively, though the diameter of the micropores created remained quite constant at approximately 200 μm. Transepidermal water loss progressively increased with increasing height of the applied microneedles and this data, like that for penetration depth, was consistent, regardless of applicant.

Conclusion

We have shown that hydrogel-forming microneedle arrays can be successfully and reproducibly applied by human volunteers given appropriate instruction. If these outcomes were able to be extrapolated to the general patient population, then use of bespoke MN applicator devices may not be necessary, thus possibly enhancing patient compliance.

KEY WORDS

microneedle patient information leaflet pharmacist skin barrier transepidermal water loss 

Notes

Acknowledgments and Disclosures

This work was supported by the Biotechnology and Biological Sciences Research Council (BB/K020234/1), the Engineering and Physical Sciences Research Council (EP/H021647/1) and the Wellcome Trust (WT094085MA). The authors report no conflict of interests, financial or otherwise.

Supplementary material

11095_2014_1301_MOESM1_ESM.jpg (175 kb)
ESM 1 (JPEG 175 kb)
11095_2014_1301_MOESM2_ESM.doc (34 kb)
ESM 2 (DOC 34 kb)
11095_2014_1301_MOESM3_ESM.doc (32 kb)
ESM 3 (DOC 32 kb)

References

  1. 1.
    Donnelly RF, Singh TRR, Morrow DIJ, Woolfson AD. Microneedle-mediated transdermal and intradermal drug delivery. Chichester: John Wiley & Sons, Ltd; 2012.CrossRefGoogle Scholar
  2. 2.
    Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev. 2012;64:1547–68.PubMedCentralPubMedCrossRefGoogle Scholar
  3. 3.
    Al-Zahrani S, Zaric, McCrudden MT, Scott C, Kissenpfennig A, Donnelly RF. Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy. Expert Opin Drug Deliv. 2012;9:541–50.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Tuan-Mahmood TM, McCrudden MT, Torrisi BM, McAlister E, Garland MJ, Singh TR, Donnelly RF. Microneedles for intradermal and transdermal drug delivery. Eur J Pharm Sci. 2013 In Press.Google Scholar
  5. 5.
    Greystone Associates. Microneedles in medicine: technology, devices, markets and prospects. Amherst: Greystone Associates; 2012.Google Scholar
  6. 6.
    Donnelly RF, Morrow DIJ, Singh TRR, Migalska K, McCarron PA, O’Mahony C, et al. Processing difficulties and instability of carbohydrate microneedle arrays. Drug Dev Ind Pharm. 2009;35:1242–54.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Donnelly RF, Majithiya R, Singh TRR, Morrow DIJ, Garland MJ, Demir YK, et al. Design and physicochemical characterisation of optimised polymeric microneedle arrays prepared by a novel laser-based micromoulding technique. Pharm Res. 2011;28:41–57.PubMedCentralPubMedCrossRefGoogle Scholar
  8. 8.
    Migalska K, Morrow DIJ, Garland MJ, Thakur RRS, Woolfson AD, Donnelly RF. Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery. Pharm Res. 2011;28:1919–30.PubMedCrossRefGoogle Scholar
  9. 9.
    Park JH, Allen MG, Prausnitz MR. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release. 2005;104:51–66.PubMedCrossRefGoogle Scholar
  10. 10.
    Donnelly RF, Singh TRR, Garland MJ, Migalska K, Majithiy R, McCrudden CM, et al. Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery. Adv Funct Mater. 2012;22:4879–90.PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Donnelly RF, Singh TR, Alkilani AZ, McCrudden MT, O’Neill S, O’Mahony C, et al. Hydrogel-forming microneedle arrays exhibit antimicrobial properties: potential for enhanced patient safety. Int J Pharm. 2013;451:76–91.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Donnelly RF, Garland MJ, Morrow DIJ, Migalska K, Thakur RRS, Majithiya R, et al. Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution. J Control Release. 2010;147:333–41.PubMedCrossRefGoogle Scholar
  13. 13.
    Olatunji O, Das DB, Garland MJ, Belaid L, Donnelly RF. Influence of array interspacing on the force required for successful microneedle skin penetration: theoretical and practical approaches. J Pharm Sci. 2013;102:1209–21.PubMedCrossRefGoogle Scholar
  14. 14.
    Li WZ, Huo MR, Zhou JP, Zhou YQ, Hao BH, Liu T, et al. Super-short solid silicon microneedles for transdermal drug delivery applications. Int J Pharm. 2010;389:122–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Davis SP, Landis BJ, Adams ZH, Allen MG, Prausnitz MR. Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. J Biomech. 2004;37:1155–63.PubMedCrossRefGoogle Scholar
  16. 16.
    Thakur RRS, Dunne NJ, Cunningham E, Donnelly RF. Review of patents on microneedle applicators. Recent Pat Drug Deliv Formul. 2011;5:11–23.CrossRefGoogle Scholar
  17. 17.
    Thakur RRS, Woolfson AD, Donnelly RF. Investigation of solute permeation across poly(ethylene glycol)-crosslinked poly (methyl vinyl ether-co-maleic acid) hydrogels. J Pharm Pharmacol. 2010;62:829–37.Google Scholar
  18. 18.
    Thakur RRS, Garland MJ, Migalska K, Caffarel-Salvador E, Shaikh R, Woolfson AD, et al. Influence of a pore-forming agent on swelling, network parameters and permeability of poly (ethylene glycol)-crosslinked poly(methyl vinyl ether-co-maleic acid) hydrogels: application in transdermal delivery systems. J Appl Polym Sci. 2012;125:2680–94.CrossRefGoogle Scholar
  19. 19.
    Medicines & Healthcare products Regulatory Agency (2013) Quality Criteria for PILs http://www.mhra.gov.uk/Howweregulate/Medicines/Labelspatientinformationleafletsandpackaging. Accessed 21st April 2013.
  20. 20.
    Giudice EL, Campbell JD. Needle-free vaccine delivery. Adv Drug Deliv Rev. 2006;58:68–89.PubMedCrossRefGoogle Scholar
  21. 21.
    Kalluri H, Kolli CS, Banga AK. Characterization of microchannels created by metal microneedles: formation and closure. AAPS J. 2011;13:473–81.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Kalluri H, Banga AK. Formation and closure of microchannels in skin following microporation. Pharm Res. 2011;28:82–94.PubMedCrossRefGoogle Scholar
  23. 23.
    Haq MI, Smith E, John DN, Kalavala M, Edwards C, Anstey A, et al. Clinical administration of microneedles: skin puncture, pain and sensation. Biomed Microdevices. 2009;11:35–47.PubMedCrossRefGoogle Scholar
  24. 24.
    Gomaa YA, Morrow DIJ, Garland MJ, Donnelly RF, El-Khordagui LK, Meidan VM. Effects of microneedle length, density, insertion time and multiple applications on human skin barrier function: assessments by transepidermal water loss. Toxicol in Vitro. 2010;24:1971–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Abelson J, Forest P-G, Eyles J, Smith P, Martin E, Gauvin FP. Deliberations about deliberative methods: issues in the design and evaluation of public participation processes. Soc Sci Med. 2003;57:239–51.PubMedCrossRefGoogle Scholar
  26. 26.
    Donnelly RF, Singh TRR, Tunney MM, Morrow DIJ, McCarro PA, O’Mahony C, et al. Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharm Res. 2009;26:2513–22.PubMedCentralPubMedCrossRefGoogle Scholar
  27. 27.
    Godin B, Touitou E. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Adv Drug Deliv Rev. 2007;59:1152–61.PubMedCrossRefGoogle Scholar
  28. 28.
    Ng KW, Pearton M, Coulman S, Anstey A, Gateley C, Morrissey A, et al. Development of an ex vivo human skin model for intradermal vaccination: tissue viability and Langerhans cell behaviour. Vaccine. 2009;27:5948–55.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Gill HS, Denson DD, Burris BA, Prausnitz MR. Effect of microneedle design on pain in human volunteers. Clin J Pain. 2008;24:585–94.PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    Bal SM, Caussin J, Pavel S, Bouwstra JA. In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci. 2008;35:193–202.PubMedCrossRefGoogle Scholar
  31. 31.
    Birchall JC, Clemo R, Anstey A, John DN. Microneedles in clinical practice-an exploratory study into the opinions of healthcare professionals and the public. Pharm Res. 2011;28:95–106.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Ryan F. Donnelly
    • 1
    Email author
  • Kurtis Moffatt
    • 1
  • Ahlam Zaid Alkilani
    • 1
    • 2
  • Eva M. Vicente-Pérez
    • 1
  • Johanne Barry
    • 1
  • Maelíosa T. C. McCrudden
    • 1
  • A. David Woolfson
    • 1
  1. 1.School of PharmacyQueens University Belfast, Medical Biology CentreBelfastUK
  2. 2.School of PharmacyZarqa UniversityZarqaJordan

Personalised recommendations